Spectrum Pharmaceuticals

.

FDA OK’s Spectrum Cancer Drug for Wider Use

Spectrum Pharmaceuticals

An Irvine drug maker, Spectrum Pharmaceuticals Inc., has said that it got regulatory approval for an expanded use of a cancer drug.

Spectrum said that the FDA approved Zevalin as an early treatment for a blood cancer, in patients with non-Hodgkin's lymphoma. The drug was used previously on patients whose tumors did not respond to other treatments.

Spectrum Pharmaceuticals inks 50:50 JV pact with Cell Therapeutics

Spectrum Pharmaceuticals inks 50:50 JV pact with Cell Therapeutics Spectrum Pharmaceuticals and Cell Therapeutics have entered into an agreement to form a 50:50 owned joint venture, RIT Oncology, to commercialize and develop Zevalin in the United States.

Latest News

Alzheimer’s, dementia to affect 3 in 10 former NFL players
Fight against Ebola is long
HSBC to Pay $550 Million in Mortgage Case Settlement
Critical Review and Suggestions for Improvement Come Olive Garden’s Way from Inv
Breast cancer is not caused by bras
World record for boob job attempted by Gold Coast clinic
Brain keeps learning even when you are sleeping
Memory can be affected by your blood type
Female Baboons with Male Friends live Longer: Study
People keeping Bees as a Hobby
Many Senior Americans Still Struggle to Repay Student Loan
Increase in Wholesale Inventories Remain Meagre
Syndicate content